Literature DB >> 16842922

Critical issues on opioids in chronic non-cancer pain: an epidemiological study.

Jørgen Eriksen1, Per Sjøgren, Eduardo Bruera, Ola Ekholm, Niels K Rasmussen.   

Abstract

The aim of the study was epidemiologically to evaluate the long-term effects of opioids on pain relief, quality of life and functional capacity in long-term/chronic non-cancer pain. The study was based on data from the 2000 Danish Health and Morbidity Survey. As part of a representative National random sample of 16,684 individuals (>16 years of age), 10,066 took part in an interview and completed a self-administered questionnaire. Cancer patients were excluded. The interview and the self-administered questionnaire included questions on chronic/long-lasting pain (>6 months), health-related quality of life (SF-36), use of the health care system, functional capabilities, satisfaction with medical pain treatment and regular or continuous use of medications. Participants reporting pain were divided into opioid and non-opioid users. The analyses were adjusted for age, gender, concomitant use of anxiolytics and antidepressants and pain intensity. Pain relief, quality of life and functional capacity among opioid users were compared with non-opioid users. Opioid usage was significantly associated with reporting of moderate/severe or very severe pain, poor self-rated health, not being engaged in employment, higher use of the health care system, and a negative influence on quality of life as registered in all items in SF-36. Because of the cross-sectional nature causative relationships cannot be ascertained. However, it is remarkable that opioid treatment of long-term/chronic non-cancer pain does not seem to fulfil any of the key outcome opioid treatment goals: pain relief, improved quality of life and improved functional capacity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842922     DOI: 10.1016/j.pain.2006.06.009

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  122 in total

1.  Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2015-09-02       Impact factor: 4.492

2.  The Cost and Burden of Chronic Pain.

Authors:  Ceri J Phillips
Journal:  Rev Pain       Date:  2009-06

3.  An exploration of opioid medication management for non-malignant pain in primary care.

Authors:  Jia Song; Jens Foell
Journal:  Br J Pain       Date:  2015-08

4.  [Interdisciplinary pain assessment in the hospital setting : Merely a door-opener to multimodal pain therapy?]

Authors:  E Sens; M Mothes-Lasch; J F Lutz
Journal:  Schmerz       Date:  2017-12       Impact factor: 1.107

5.  Regulation of opioid prescribing.

Authors:  Jane C Ballantyne
Journal:  BMJ       Date:  2007-04-21

Review 6.  Nonmedical use of prescription opioids: motive and ubiquity issues.

Authors:  James P Zacny; Stephanie A Lichtor
Journal:  J Pain       Date:  2008-03-14       Impact factor: 5.820

7.  [Addition is also a disease].

Authors:  C Maier
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

Review 8.  [Pain inhibition by opioids-new concepts].

Authors:  C Stein
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

Review 9.  [Options for pain therapy of urologic chronic pelvic pain syndrome (UCPPS)].

Authors:  O Moormann
Journal:  Urologe A       Date:  2009-10       Impact factor: 0.639

10.  Opioid prescriptions for chronic pain and overdose: a cohort study.

Authors:  Kate M Dunn; Kathleen W Saunders; Carolyn M Rutter; Caleb J Banta-Green; Joseph O Merrill; Mark D Sullivan; Constance M Weisner; Michael J Silverberg; Cynthia I Campbell; Bruce M Psaty; Michael Von Korff
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.